🇪🇺 NGENLA (Somatrogon) in European Union

NGENLA (Somatrogon) (ngenla-somatrogon) regulatory status in European Union.

Marketing authorisation

EMA

  • Status: approved

NGENLA (Somatrogon) in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Hematology approved in European Union

Frequently asked questions

Is NGENLA (Somatrogon) approved in European Union?

Yes. EMA has authorised it.

Who is the marketing authorisation holder for NGENLA (Somatrogon) in European Union?

Pfizer is the originator. The local marketing authorisation holder may differ — check the official source linked above.